Umit Topaloglu Selected Research

Adenocarcinoma

12/2018

Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Umit Topaloglu Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 10/2009
3	Squamous Cell Carcinoma of Head and Neck 11/2021 - 01/2021
2	Breakthrough Infections 01/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
2	COVID-19 01/2022 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2021
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 11/2021 - 06/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Ischemia 01/2008 - 01/2007
2	Reperfusion Injury 01/2008 - 01/2007
1	Rheumatoid Arthritis 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	HIV Infections (HIV Infection) 01/2022
1	COVID-19 breakthrough infections 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Multiple Sclerosis 01/2022
1	Multiple Myeloma 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2018
1	Adenocarcinoma 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Necrosis 01/2017
1	Brain Diseases (Brain Disorder) 01/2013
1	Pancreatitis 02/2009
1	Decapitation 02/2009
1	Inflammation (Inflammations) 02/2009
1	Stomach Neoplasms (Stomach Cancer) 01/2009
1	Fibrosis (Cirrhosis) 06/2007
1	Ulcer 01/2004
1	Gastritis 01/2004

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 01/2017
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2021
2	Circulating Tumor DNAIBA 06/2021 - 01/2021
2	Grape Seed ExtractIBA 01/2008 - 06/2007
2	AntioxidantsIBA 01/2008 - 01/2007
1	VaccinesIBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Nicotine FDA Link 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2021
1	GenieIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	LigandsIBA 12/2018
1	Contrast MediaIBA 09/2018
1	Leucovorin (Folinic Acid)FDA Link 01/2017
1	folfirinoxIBA 01/2017
1	EnzymesIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	devimistatIBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	MethyltransferasesIBA 01/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Indicators and Reagents (Reagents)IBA 10/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	Oxygen (Dioxygen)IBA 10/2009
1	LuminolIBA 02/2009
1	10,10'-dimethyl-9,9'-biacridinium (Lucigenin)IBA 02/2009
1	CeruletideIBA 02/2009
1	Adenosine Triphosphatases (ATPase)IBA 02/2009
1	proanthocyanidinIBA 02/2009
1	Thioctic Acid (Lipoic Acid)IBA 01/2007
1	Oxidants (Oxidizing Agents)IBA 01/2007
1	Famotidine (Pepcid)FDA LinkGeneric 01/2004
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2004

Therapy/Procedure

3	Immunotherapy 11/2021 - 01/2020
2	Therapeutics 10/2021 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2017
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Ambulatory Care (Outpatient Care) 01/2020
1	Radiotherapy 01/2017
1	Injections 02/2009
1	Lymph Node Excision (Lymph Node Dissection) 01/2009